HLF - HERBALIFE LTD.
17.74
-1.500 -8.455%
Share volume: 1,741,420
Last Updated: 03-03-2026
Wholesale/Wholesale – Drugs & Drug Proprietaries:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$19.24
-1.50
-0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-01-2024 | 07-31-2024 | 10-30-2024 | 02-19-2025 | 04-30-2025 | 08-06-2025 | 11-05-2025 | 02-18-2026 | |
| Assets | |||||||||
| Total Assets | 2.647 B | 2.602 B | 2.654 B | 2.728 B | 2.684 B | 2.736 B | 2.697 B | 2.786 B | |
| Current Assets | 1.226 B | 1.214 B | 1.245 B | 1.144 B | 1.094 B | 1.103 B | 1.106 B | 1.145 B | |
| Inventories | 501.900 M | 480.700 M | 515.300 M | 475.400 M | 488.000 M | 513.100 M | 512.500 M | 511.700 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 398.300 M | 374.000 M | 402.500 M | 415.300 M | 329.400 M | 320.900 M | 305.500 M | 353.100 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 510.900 M | 468.200 M | 463.300 M | 460.200 M | 450.300 M | 465.800 M | 456.700 M | 447.700 M | |
| Other Assets | 909.900 M | 920.200 M | 945.600 M | 1.124 B | 1.140 B | 1.167 B | 1.134 B | 1.194 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.647 B | 2.602 B | 2.654 B | 2.728 B | 2.684 B | 2.736 B | 2.697 B | 2.786 B | |
| Total liabilities | 3.684 B | 3.639 B | 3.608 B | 3.529 B | 3.420 B | 3.391 B | 3.303 B | 3.295 B | |
| Total current liabilities | 944.700 M | 976.200 M | 1.285 B | 1.230 B | 1.129 B | 1.094 B | 999.900 M | 1.013 B | |
| Accounts Payable | 89.900 M | 81.300 M | 86.600 M | 70.000 M | 85.400 M | 91.800 M | 88.100 M | 99.800 M | |
| Other liabilities | 333.900 M | 342.200 M | 344.800 M | 322.200 M | 316.300 M | 322.700 M | 306.100 M | 310.700 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 2.405 B | 2.321 B | 1.978 B | 1.977 B | 1.975 B | 1.974 B | 1.997 B | 1.972 B | |
| Other liabilities | 333.900 M | 342.200 M | 344.800 M | 322.200 M | 316.300 M | 322.700 M | 306.100 M | 310.700 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -1.037 B | -1.037 B | -954.200 M | -801.100 M | -736.000 M | -660.500 M | -612.000 M | -515.100 M | |
| Common stock | 244.300 M | 253.500 M | 267.100 M | 278.300 M | 288.000 M | 294.400 M | 304.700 M | 316.100 M | |
| Retained earnings | -1.038 B | -1.033 B | -985.900 M | -808.000 M | -757.600 M | -708.300 M | -665.100 M | -579.700 M |